<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA Psychiatry: Functional Impairment Topic Collection</title>
    <link>http://archpsyc.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Thu, 01 Mar 2012 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 01 Jan 2013 00:46:57 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@archpsyc.jamanetwork.com</managingEditor>
    <webMaster>webmaster@archpsyc.jamanetwork.com</webMaster>
    <item>
      <title>Functional Impairment in Elderly Patients With Mild Cognitive Impairment and Mild Alzheimer Disease Impairment in MCI and AD Patients </title>
      <link>http://archpsyc.jamanetwork.com/article.aspx?articleID=211303</link>
      <pubDate>Mon, 06 Jun 2011 00:00:00 GMT</pubDate>
      <author>Brown PJ, Devanand DP, Liu X, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Context&lt;/div&gt;The original mild cognitive impairment (MCI) criteria exclude substantial functional deficits, but recent reports suggest otherwise. Identifying the extent, severity, type, and correlates of functional deficits that occur in MCI and mild Alzheimer disease (AD) can aid in early detection of incipient dementia and can identify potential mechanistic pathways to disrupted instrumental activities of daily living (IADLs).&lt;div class="boxTitle"&gt;Objectives&lt;/div&gt;To examine the number, type, and severity of functional impairments and to identify the clinical characteristics associated with functional impairment across patients with amnestic MCI (aMCI) and those with mild AD.&lt;div class="boxTitle"&gt;Design&lt;/div&gt;Study using baseline data from the Alzheimer's Disease Neuroimaging Initiative.&lt;div class="boxTitle"&gt;Setting&lt;/div&gt;Multiple research sites in the United States and Canada.&lt;div class="boxTitle"&gt;Patients&lt;/div&gt;Samples included 229 control individuals, 394 patients with aMCI, and 193 patients with AD.&lt;div class="boxTitle"&gt;Main Outcome Measure&lt;/div&gt;The 10-item Pfeffer Functional Activities Questionnaire (FAQ) assessed function.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;Informant-reported FAQ deficits were common in patients with aMCI (72.3%) and AD (97.4%) but were rarely self-reported by controls (7.9%). The average severity per FAQ deficit did not differ between patients with aMCI and controls; both were less impaired than patients with AD (&lt;span style="font-style:italic;"&gt;P&lt;/span&gt; &lt; .001). Two FAQ items (remembering appointments, family occasions, holidays, and medications and assembling tax records, business affairs, or other papers) were specific (specificity estimate, 0.95) in differentiating the control group from the combined aMCI and AD groups (only 34.0% of patients with aMCI and 3.6% of patients with AD had no difficulty with these 2 items). The severity of FAQ deficits in the combined aMCI and AD group was associated with worse Trail Making Test, part A scores and smaller hippocampal volumes (&lt;span style="font-style:italic;"&gt;P&lt;/span&gt; &lt; .001 for both). Within the aMCI group, functionally intact individuals had greater hippocampal volumes and better Auditory Verbal Learning Test 30-minute delay and Trail Making Test, part A (&lt;span style="font-style:italic;"&gt;P&lt;/span&gt; &lt; .001 for each) scores compared with individuals with moderate or severe FAQ deficits. Patients with a high number of deficits were more likely to express the apolipoprotein &lt;span style="font-style:italic;"&gt;ε4&lt;/span&gt; allele (63.8%) compared with patients with no (46.8%) or few (48.4%) functional deficits.&lt;div class="boxTitle"&gt;Conclusions&lt;/div&gt;Mild IADL deficits are common in individuals with aMCI and should be incorporated into MCI criteria. Two IADLs—remembering appointments, family occasions, holidays, and medications and assembling tax records, business affairs, or other papers—appear to be characteristic of clinically significant cognitive impairment. In patients with aMCI, impairment in memory and processing speed and greater medial temporal atrophy were associated with greater IADL deficits.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">68</prism:volume>
      <prism:number xmlns:prism="prism">6</prism:number>
      <prism:startingPage xmlns:prism="prism">617</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">626</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/archgenpsychiatry.2011.57</prism:doi>
      <guid>http://archpsyc.jamanetwork.com/article.aspx?articleID=211303</guid>
    </item>
  </channel>
</rss>